全文获取类型
收费全文 | 3487篇 |
免费 | 569篇 |
国内免费 | 168篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 38篇 |
妇产科学 | 60篇 |
基础医学 | 616篇 |
口腔科学 | 131篇 |
临床医学 | 360篇 |
内科学 | 559篇 |
皮肤病学 | 103篇 |
神经病学 | 165篇 |
特种医学 | 75篇 |
外国民族医学 | 1篇 |
外科学 | 276篇 |
综合类 | 460篇 |
预防医学 | 82篇 |
眼科学 | 74篇 |
药学 | 321篇 |
1篇 | |
中国医学 | 72篇 |
肿瘤学 | 802篇 |
出版年
2024年 | 6篇 |
2023年 | 75篇 |
2022年 | 100篇 |
2021年 | 237篇 |
2020年 | 234篇 |
2019年 | 228篇 |
2018年 | 190篇 |
2017年 | 247篇 |
2016年 | 235篇 |
2015年 | 381篇 |
2014年 | 415篇 |
2013年 | 391篇 |
2012年 | 299篇 |
2011年 | 318篇 |
2010年 | 261篇 |
2009年 | 136篇 |
2008年 | 125篇 |
2007年 | 76篇 |
2006年 | 49篇 |
2005年 | 32篇 |
2004年 | 27篇 |
2003年 | 22篇 |
2002年 | 30篇 |
2001年 | 12篇 |
2000年 | 11篇 |
1999年 | 15篇 |
1998年 | 9篇 |
1997年 | 5篇 |
1996年 | 7篇 |
1995年 | 7篇 |
1994年 | 7篇 |
1993年 | 8篇 |
1992年 | 3篇 |
1991年 | 6篇 |
1990年 | 1篇 |
1989年 | 6篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有4224条查询结果,搜索用时 62 毫秒
1.
目的 探讨血清微小RNA-210(mircoRNA-210,miR-210)与新生儿呼吸窘迫综合征(neonatalrespiratory distress syndrome,NRDS)严重程度和预后的关系。
方法 收集NRDS患儿104例,根据预后分为生存组与死亡组。所有新生儿根据首次胸部X线片结果与病情严重程度分为轻度组(Ⅰ级、Ⅱ级)与重度组(Ⅲ级、Ⅳ级)。比较死亡组与生存组患儿一般资料,轻度组与重度组血清miR-210水平与新生儿急性生理学评分围生期补充Ⅱ(perinatal supplement of acute physiological score for neonates Ⅱ,SNAPPE-Ⅱ)评分。绘制ROC曲线分析血清miR-210水平对NRDS患儿死亡的预测价值。采用Spearman相关性分析NRDS发生与血清miR-210的相关性。
结果 根据预后分组,104例患儿中预后较好81例(77.88%),死亡23例(22.12%)。生存组miR-210水平、SNAPPE-Ⅱ评分低于死亡组(P<0.05);2组性别、胎龄、出生体重、母亲年龄、病因、剖宫产、双胎、羊水异常差异无统计学意义(P>0.05)。按照胸部X线片表现分组,104例患儿轻度患儿73例,重度患儿31例。轻度组miR-210水平、SNAPPE-Ⅱ评分低于重度组(P<0.05)。NRDS发生与血清miR-210水平呈正相关(r=0.638,P<0.001)。血清miR-210与SNAPPE-Ⅱ评分呈正相关(r=0.513,P<0.05)。血清miR-210的最佳分界值为16.71 ng/L时,曲线下面积为0.763,OR=0.846,95%CI:0.892~1.064,敏感度为82.61%,特异度为86.42%。结论 血清miR-210水平升高与NRDS病情严重程度以及预后密切相关,血清miR-210水平与NRDS病情程度呈正相关性,当血清miR-210临界值为16.71 ng/L时对评估NRDS患儿预后具有较高价值。 相似文献
2.
Jacob Fredsøe Anne K.I. Rasmussen Peter Mouritzen Michael Borre Torben Ørntoft Karina D. Sørensen 《International journal of cancer. Journal international du cancer》2019,145(9):2558-2567
Improved biomarkers for prostate cancer (PC) risk stratification are urgently needed. Here, we aimed to develop a novel multimarker model for prediction of biochemical recurrence (BCR) after curatively intended radical prostatectomy (RP), based on minimally invasive sampling of blood and urine. We initially measured the levels of 45 selected miRNAs by RT-qPCR in exosome enriched cell-free urine samples collected prior to RP from 215 PC patients (Cohort 1, training). We trained a novel logistic regression model (pCaP), comprising five urine miRNAs (miR-151a-5p, miR-204-5p, miR-222-3p, miR-23b-3p and miR-331-3p) and serum prostate-specific antigen (PSA), which significantly predicted time to BCR in Cohort 1 (univariate Cox regression analysis: HR = 3.12, p < 0.001). Next, using the same exact numeric cutoff for dichotomization as trained in Cohort 1, we tested and successfully validated the prognostic potential of pCaP in two additional cohorts, including 199 (Cohort 2, HR = 2.24, p = 0.002) and 205 (Cohort 3, HR = 2.15, p = 0.004) RP patients, respectively. pCaP remained a significant predictor of BCR, also after adjustment for pathological T-stage, surgical margin status and Gleason grade group (p < 0.05 in multivariate Cox regression analysis: HR = 2.72, 1.94 and 1.83 for Cohorts 1, 2 and 3, respectively). Additionally, pCaP scores correlated positively with the established clinical risk stratification nomogram CAPRA in all three PC cohorts (Pearson's rho: 0.45, 0.39 and 0.44). Together, our results suggest that the minimally invasive pCaP model could potentially be used in the future to improve PC risk stratification and to guide more personalized treatment decisions. Further clinical validation studies are warranted. 相似文献
3.
Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients 下载免费PDF全文
4.
乳腺癌作为一种复杂的、表型多样性的遗传性疾病,涉及基因表达和各种结构的变化。如何早期诊断乳腺癌,降低乳腺癌发病率、死亡率一直是大众关注的焦点。微小RNA(microRNA)是一类内源性非编码单链RNA,广泛参与乳腺癌细胞的增殖、分化、凋亡等生理过程,并与乳腺癌患者的临床分期、淋巴结转移、远处转移等相关。现就microRNA在乳腺癌发生、发展过程中的作用,及其在该病诊疗过程中的应用作一综述,以期为乳腺癌的进一步研究提供新的思路。 相似文献
5.
Bioactive Compounds in the Ethanol Extract of Marine Sponge Stylissa carteri Demonstrates Potential Anti-Cancer Activity in Breast Cancer Cells 下载免费PDF全文
Muhammad Hasan Bashari Fathul Huda Tamia S TartilaSarah ShabrinaTenny PutriNurul QomarillaHarold AtmajaBeginer SubhanIkhwan Resmala SudjiEdy Meiyanto 《Asian Pacific journal of cancer prevention》2019,20(4):1199-1206
Objective: Despite advanced treatment options available, drug resistance develops in breast cancer (BC) patientsrequiring novel effective drugs. Stylissa carteri, a marine sponge predominantly living in Indonesia territories, hasnot been extensively studied as anti-cancer. Therefore, this study targeted to assess the anti-tumor activity of theethanol extract of S. carteri in BC cells. Methods: S. carteri was collected from Pramuka Island, at Kepulauan SeribuNational Park, Jakarta, Indonesia and extracted using ethanol. Different BC cells including MDA MB 231, MDAMB 468, SKBR3, HCC-1954 and MCF-7 cells were treated with this extract for cytotoxic analysis using MTT assay.Spheroid growth assay and apoptosis assay were conducted in HCC-1954 cells. In addition, cell migration analysis andsynergistic activity with doxorubicin or paclitaxel were conducted in MDA MB 231 cells. This extract was subjectedalso for GC-MS analysis. Results: The results show that ethanol extract of S. carteri demonstrated a cytotoxic activityin BC cells. The IC50 of this extract was lower 15 μg/ml in MDA MB 231, MDA MB 468, SKBR3, and HCC-1954cells. Moreover, this extract inhibited spheroids growth and induced apoptosis in HCC-1954 cells. It inhibited cellmigration and demonstrated a synergistic activity with doxorubicin or paclitaxel on triggering cell death in MDA MB231 cells. Furthermore, GC-MS analysis indicated that this extract contained 1,2-Benzenediol, Dibutyl phthalate and9,12-Octadecadienoic acid, ethyl ester. Conclusion: Our preliminary data indicate a potential anti-tumor activity ofethanol extract of S. carteri in breast cancer cells. 相似文献
6.
7.
8.
9.
10.